Q02083 (NAAA_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 103.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: N-acylethanolamine-hydrolyzing acid amidase EC=3.5.1.- Alternative name(s): Acid ceramidase-like protein N-acylsphingosine amidohydrolase-like Short name=ASAH-like protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 359 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Degrades bioactive fatty acid amides to their corresponding acids, with the following preference: N-palmitoylethanolamine > N-myristoylethanolamine > N-lauroylethanolamine = N-stearoylethanolamine > N-arachidonoylethanolamine > N-oleoylethanolamine. Also exhibits weak hydrolytic activity against the ceramides N-lauroylsphingosine and N-palmitoylsphingosine. Ref.2 |
| Enzyme regulation | Stimulated by DTT and Nonidet P-40. Ref.2 |
| Subcellular location | |
| Tissue specificity | Expressed in numerous tissues, with highest levels in liver and kidney, followed by pancreas. Ref.1 |
| Post-translational modification | N-glycosylated. Tunicamycin treatment causes a reduction in specific activity against N-palmitoylethanolamine. Ref.2 Ref.5 |
| Sequence similarities | Belongs to the acid ceramidase family. |
| Biophysicochemical properties | Kinetic parameters: KM=97 µM for N-palmitoylethanolamine Ref.2 pH dependence: Optimum pH is 4.5 with N-palmitoylethanolamine as substrate. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Lysosome |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Signal |
| Molecular function | Hydrolase |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | lipid metabolic process Inferred from electronic annotation. Source: InterPro |
| Cellular component | lysosome Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | hydrolase activity Inferred from electronic annotation. Source: UniProtKB-KW transcription factor bindingInferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q02083-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q02083-2) The sequence of this isoform differs from the canonical sequence as follows: 324-359: Missing. | ||||||
| Isoform 3 (identifier: Q02083-3) The sequence of this isoform differs from the canonical sequence as follows: 198-199: KG → PE 200-359: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Potential | ||||||
| Chain | 29 – 359 | 331 | N-acylethanolamine-hydrolyzing acid amidase | PRO_0000002318 | |||||
Amino acid modifications | |||||||||
| Glycosylation | 37 | 1 | N-linked (GlcNAc...) Ref.5 | ||||||
| Glycosylation | 107 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 309 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 315 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 333 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 198 – 199 | 2 | KG → PE in isoform 3. | VSP_000328 | |||||
| Alternative sequence | 200 – 359 | 160 | Missing in isoform 3. | VSP_000329 | |||||
| Alternative sequence | 324 – 359 | 36 | Missing in isoform 2. | VSP_000330 | |||||
| Natural variant | 107 | 1 | N → K. Corresponds to variant rs34751328 [ dbSNP | Ensembl ]. | VAR_048336 | |||||
| Natural variant | 151 | 1 | V → I. Corresponds to variant rs4859571 [ dbSNP | Ensembl ]. | VAR_028428 | |||||
| Natural variant | 334 | 1 | F → L. Corresponds to variant rs6823734 [ dbSNP | Ensembl ]. | VAR_048337 | |||||
Experimental info | |||||||||
| Sequence conflict | 147 | 1 | P → A in AAA60119. Ref.4 | ||||||
| Sequence conflict | 240 | 1 | T → S in AAA60119. Ref.4 | ||||||
| Sequence conflict | 250 | 1 | V → L in AAA60119. Ref.4 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and characterization of a human cDNA and gene encoding a novel acid ceramidase-like protein." Hong S.-B., Li C.-M., Rhee H.-J., Park J.-H., He X., Levy B., Yoo O.J., Schuchman E.H. Genomics 62:232-241(1999) [PubMed: 10610717] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR LOCATION. Tissue: Placenta. |
| [2] | "Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase." Tsuboi K., Sun Y.-X., Okamoto Y., Araki N., Tonai T., Ueda N. J. Biol. Chem. 280:11082-11092(2005) [PubMed: 15655246] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, GLYCOSYLATION. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Muscle. |
| [4] | "A human endogenous long terminal repeat provides a polyadenylation signal to a novel, alternatively spliced transcript in normal placenta." Goodchild N.L., Wilkinson D.A., Mager D.L. Gene 121:287-294(1992) [PubMed: 1446826] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 81-359 (ISOFORM 2). Tissue: Placenta. |
| [5] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-37, MASS SPECTROMETRY. Tissue: Liver. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB161353 mRNA. Translation: BAD88528.1. BC006388 mRNA. Translation: AAH06388.2. BC011854 mRNA. No translation available. M92449 mRNA. Translation: AAA60119.1. |
| IPI | IPI00024083. IPI00028879. IPI00215844. |
| RefSeq | NP_001035861.1. NM_001042402.1. NP_055250.2. NM_014435.3. |
| UniGene | Hs.437365. |
3D structure databases | |
| ProteinModelPortal | Q02083. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q02083. |
Protein family/group databases | |
| MEROPS | C89.002. |
Polymorphism databases | |
| DMDM | 116241258. |
Proteomic databases | |
| PRIDE | Q02083. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000286733; ENSP00000286733; ENSG00000138744. |
| GeneID | 27163. |
| KEGG | hsa:27163. |
| NMPDR | fig|9606.3.peg.24272. |
| UCSC | uc003hja.1. human. uc003hjb.1. human. uc010iiz.1. human. |
Organism-specific databases | |
| CTD | 27163. |
| GeneCards | GC04M076831. |
| H-InvDB | HIX0021970. |
| HGNC | HGNC:736. NAAA. |
| HPA | CAB026135. |
| MIM | 607469. gene. |
| neXtProt | NX_Q02083. |
| PharmGKB | PA162396672. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG14681. |
| GeneTree | ENSGT00530000063548. |
| HOGENOM | HBG561443. |
| HOVERGEN | HBG050586. |
| InParanoid | Q02083. |
| OMA | RWLPVLR. |
| OrthoDB | EOG46MBK4. |
| PhylomeDB | Q02083. |
Gene expression databases | |
| ArrayExpress | Q02083. |
| Bgee | Q02083. |
| CleanEx | HS_NAAA. |
| Genevestigator | Q02083. |
| GermOnline | ENSG00000138744. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR016699. Acid_ceramidase-like. IPR003199. Chologlycine_hydro. [Graphical view] |
| KO | K13720. |
| Pfam | PF02275. CBAH. 1 hit. [Graphical view] |
| PIRSF | PIRSF017632. Acid_ceramidase-like. 1 hit. |
| ProtoNet | Search... |
Other | |
| NextBio | 49950. |
| SOURCE | Search... |
Entry information
| Entry name | NAAA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q02083 Secondary accession number(s): Q5KTF2, Q96EY2, Q9BRA8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with